Immutep Limited Profit Margin

The latest profit margin for IMMP is -650.96% as of June 2026. That compares with -1470.91% in the prior-year period — up 55.7% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Immutep Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMP's profit margin moved from -1470.91% to -650.96% — a 55.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immutep Limited's valuation or profitability profile.

Against Healthcare companies, IMMP currently prints -650.96% for profit margin, while the sector average sits near 10.58%. That is roughly 6252.5% below the sector mean. Large gaps often invite a closer look at Immutep Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Immutep Limited converts resources into returns. At -650.96%, IMMP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1470.91% in the prior-year period — up 55.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IMMP's profit margin (-650.96%), review year-over-year change from -1470.91%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.